The other thing will be that there's a process that is taking place by the national advisory committee on immunization, which will be recommending how the vaccines, when they are available, should be used, how they should be rolled out and who should have priority. Those recommendations will be federal recommendations made to the provinces, and then each province will interpret those based on their own population. The vaccine will be rolled out based on that prioritization.
That's very similar to what was done with the H1N1 pandemic. A process will take place. It will take into account bioethics, the epidemiology, the effectiveness of the vaccine on different populations, etc.